
Menaril8 mg
Incepta Pharmaceuticals Ltd.
Betahistine Dihydrochloride is indicated for the symptomatic treatment of the following conditions: Established/Approved Uses Meniere's disease: Reduces the frequency and severity of vertigo…
Betahistine Dihydrochloride is indicated for the symptomatic treatment of the following conditions:
Betahistine Dihydrochloride is intended for long-term, regular use to reduce the frequency and intensity of vertigo episodes over time. It is not effective for treating an acute vertigo attack that is already in progress, and patients should be counselled accordingly to set realistic expectations.
| Indication | Recommended Dose |
|---|---|
| Meniere's disease / vestibular vertigo | Usual starting dose: 8-16 mg three times daily, taken with food. Maintenance dose typically ranges from 24-48 mg per day in divided doses, adjusted according to individual response. Some patients may benefit from a higher initial dose which can be reduced during maintenance therapy. |
Use of Betahistine Dihydrochloride in children and adolescents under 18 years is not recommended, as safety and efficacy have not been established in this age group. See Use in Special Populations.
No specific dose adjustment has been established for patients with renal or hepatic impairment based on available clinical experience; however, such patients should be monitored and use should be guided by a physician.
Betahistine Dihydrochloride tablets should be taken with food to minimize the risk of gastrointestinal discomfort. Treatment response should be reviewed periodically by the prescribing physician, and the benefit of continued treatment should be reassessed if no improvement is observed within a few months.
Betahistine Dihydrochloride is generally well tolerated. Reported side effects include:
Most gastrointestinal side effects can be reduced by taking Betahistine Dihydrochloride with food. Patients should seek medical attention if they experience signs of a severe allergic reaction (e.g., swelling of the face/throat, difficulty breathing).
Betahistine Dihydrochloride is contraindicated in the following conditions:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.